Finally, the aberrant activation of the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) pathway has gained increasing interest for its potential role in DDLPS. This evidence concerns the gene AKT1 and dedifferentiated liposarcoma.